Researchers: White House Misstates Timeline of Declining U.S. Drug Overdose Deaths

The White House announced this week that U.S. drug overdose deaths have fallen to their lowest level in roughly a decade — nearly 50,000 lives saved each year — but leading drug policy researchers say the administration’s claim that the gains occurred “primarily over the last 18 months” misstates the timeline: CDC data show the decline began in 2023, under President Biden.

What was announced was a triumph measured in months of the current administration. What the underlying data show is a decline running 39 consecutive months — with most of the improvement logged before Donald Trump returned to office. That gap between political narrative and epidemiological record is the story, and it matters because researchers still do not fully understand why deaths surged or why they are now falling so steeply.

“The historic decline in drug overdose deaths demonstrates that America is unequivocally winning the fight against illicit drugs,” said Sara Carter, director of the White House Office of National Drug Control Policy, in a statement crediting heightened border security and claimed success dismantling “narco-terrorist” organizations. The statement cited “an approximately 41.5% decrease in total drug overdose deaths compared to the peak under the previous administration.”

“Since the spring of 2023, we have seen a steady decline in overdose deaths,” said Vanda Felbab-Brown, a drug policy expert at the Brookings Institution. “The fact that it has been sustained is very important.”

Families look on as President Donald Trump speaks during a ceremony to sign the "Halt All Lethal Trafficking of Fentanyl
Photo: wutc.org

Overdose deaths falling at record pace

  • Overdose deaths are genuinely falling — the steepest sustained drop on record — but the decline began before the current administration took office.
  • Fentanyl remains the leading cause of drug deaths nationwide, so the risk has not disappeared; it has diminished.
  • Researchers warn proposed Medicaid cuts could reverse the trend, because Medicaid is the largest funder of addiction treatment in the United States.

Two numbers, two timelines

The White House figure of 41.5% is measured from the peak, which occurred during the Biden administration’s first two years, amid the COVID-19 pandemic. By the time Biden left office, fatal overdoses had already dropped by roughly one-third — an improvement addiction experts at the time described as unprecedented.

Nabarun Dasgupta, a street drug researcher at the University of North Carolina at Chapel Hill, was among the first scientists to detect the drop. He said the trend began in some regions and demographic groups as early as 2021 and gained momentum nationwide. “It was really the period early 2024 through spring 2025 where we were seeing the greatest rate of decline that we’ve ever seen,” Dasgupta said.

The history of the epidemic itself cuts across administrations. According to the CDC, deaths from fentanyl smuggled from Mexico first began rising in 2013, during the Obama presidency, and accelerated during Trump’s first term. The crisis and its partial reversal both span multiple governments.

Researchers: White House Misstates Timeline of Declining U.S. Drug Overdose Deaths
Photo: opb.org

What actually drove the decline

Dasgupta, Felbab-Brown and other addiction experts credit the Biden administration with policy responses that included wider access to healthcare, broader availability of naloxone — the medication that reverses opioid overdoses by displacing the drug from receptors in the brain — and a November 2023 agreement with China, reached when Biden met President Xi Jinping in Woodside, California, to curtail shipments of industrial chemicals used to make fentanyl.

The Biden team also recorded significant interdiction wins against the Mexican cartels smuggling the drug, Felbab-Brown said.

Dasgupta and Felbab-Brown both said the improvements have continued under Trump. They said it’s important to have an accurate timeline of the overdose crisis because researchers are still trying to understand why deaths involving fentanyl surged.

Asked about Biden-era progress, Carter blamed the prior administration for the surge itself. “While drug overdose deaths eventually began to decline following the peak, the Biden Administration doesn’t get to take credit for overseeing the highest drug overdose numbers in history, then bringing them down from their own failure,” she said.

Responding to the CDC data showing an earlier start to the decline, she added, “this could be misinterpreted as progress on a graph, but it was not progress.”

According to Carter, the Trump administration is now well-positioned to build on overdose death reductions made over the last three years, in part by maintaining border security and by continuing to “relentlessly attack” drug gangs. “We are dismantling and eliminating the violent cartels and drug trafficking organizations through coordinated operations,” she said.

Claim vs. record White House statement CDC data cited by researchers
Duration of decline About 18 months At least 39 consecutive months
Start of decline Under current administration 2023, under prior administration
Progress by end of Biden term Not disclosed Roughly one-third drop already achieved
Overall reduction vs. peak Approximately 41.5% Consistent with CDC figures

Why the accurate timeline matters clinically

Epidemiologists need a correct chronology to identify which interventions worked. If the decline began in 2023, candidate explanations include expanded naloxone distribution, treatment access, the China precursor deal, and changes in the illicit drug supply itself — not border measures enacted afterward. Attributing the trend to the wrong policies could steer future funding away from what is actually saving lives.

Dasgupta raised a further concern about whether the trend can hold. The Congressional Budget Office has estimated that Medicaid cuts could mean as many as 10 million Americans losing access to health insurance coverage. “Medicaid is the largest funder of addiction services in the United States,” Dasgupta said. “Cutting Medicaid eligibility or making it harder to access forms of effective addiction treatment is guaranteed to leave people out in the cold.”

Fentanyl still leads drug deaths

Despite the decline, fentanyl remains the leading cause of drug deaths in the United States.

What remains unresolved

Carter said the administration is now positioned to build on the reductions by maintaining border security and continuing to “relentlessly attack” drug gangs through coordinated operations. Whether that approach sustains the trend, or whether treatment funding cuts undercut it, is the open question. The researchers’ point stands: the steepest decline ever recorded is real, and so is the fact that it began three years before the announcement claiming it.

References

  • Centers for Disease Control and Prevention, National Center for Health Statistics — Drug Overdose Data
  • White House Office of National Drug Control Policy statement, November 2026 — U.S. Drug Overdose Deaths Decrease
  • Centers for Disease Control and Prevention — Understanding the Opioid Overdose Epidemic
  • U.S. Government Accountability Office — Fentanyl Continues to Be Leading Cause of Overdose Deaths
  • NPR reporting, November 18, 2026, corroborated by WUTC, OPB and WFDD

This article is journalistic coverage of public health data and policy and is not a substitute for individual medical advice.

Photo of author

Health Desk

Health Desk at Archyde.

Skydance CEO David Ellison Says Federal Tax Credit Would Save Below-The-Line Jobs

Dr. Renee Hoenderkamp Announces Pregnancy at 59 via IVF